Allan G Kermode, MD, MBBS, FRCP is an expert in Neurology at Sir Charles Gairdner Hospital (Australia). As of October 2026, ScienceLeadR ranks Allan G Kermode in the top 1% of experts worldwide for Multiple Sclerosis and Autoimmune Diseases. Allan G Kermode has authored 301 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 833 (community average: 125). How the SLR is computed.

LeadR Profile

Allan G Kermode, MD, MBBS, FRCP Sir Charles Gairdner Hospital Australia
833 ScienceLeadR Reputation 833
Network Map

Neurology

Subspecialties: Immunology - Neurosurgery - Psychiatry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

I graduated from the University of Western Australia and was awarded the Medicinae Studii Princeps – the Australian Medical Association Gold Medal, in addition to the prizes in both Medicine and Surgery. I am a Fellow of the Royal Australasian College of Physicians and the Royal College of Physicians (London) and have worked in the Oxford University Department of Neurology and the Institute of Molecular Medicine Oxford, The National Hospital for Neurology and Neurosurgery, Queen Square, London UK, the Heidelberg Kopfklinic, and in the National Institutes of Health, USA. I have served as Honorary Secretary, Council Member and Coordinator of Advanced Training for the Australian and New Zealand Association of Neurologists and am an Inaugural Member of the Central Scientific Committee, Vice President and Treasurer of the Pan Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS). I am a member of the International Multiple Sclerosis Genetics Consortium (IMSGC) and ANZGene. I serve as the Chairman of the MSRA Haematological Stem Cell Transplant Committee, and have served as a member of the MSRA Brain Bank Scientific Advisory Committee. I am currently a permanent member of the Multiple Sclerosis Australia Research Management Committee. I was the Head of the Department of Neurology and Clinical Neurophysiology at Sir Charles Gairdner Hospital, and I am currently the Director of the Demyelinating Diseases Centre at the Perron Institute, Adjunct Professor of Neuroimmunology at Murdoch University, Clinical Professor of Neurology at the University of Western Australia, and previously Visiting Professor at Sun Yat Sen University, PR China. I am Deputy Director of the Professional Services Review, Chair of Neurology Panel, and Member of the Professional Services Review Panel, an independent Commonwealth Statutory Agency directly responsible to the Minister for Health for maintaining the regulation and integrity of Australia’s MBS and PBS system. I am Chairman of the International Outreach Advisory Committee of the International Skills and Training Institute of Health charity http://www.istih.org. I am Director and Founder of the Eye Wall Foundation Limited, a registered Health Promotion Charity and registered Advancing Health Charity for neurological research which attests to my commitment and responsibility to public service. I have received numerous postgraduate awards and I was a National Health and Medical Research Council (NHMRC) CJ Martin Scholar. I established the comprehensive Western Australian clinical database of over 2,400 MS patients with comprehensive long-term follow-up, have been involved in numerous international multicentre MS drug trials for many years, and I have published widely. My work has directly influenced current global medical practice, treatment, and government policy. I have extensive experience in MS epidemiology, clinical trials and neuroimaging, and I have served and continue to serve on numerous national and international scientific advisory boards in a leadership role for government, academic sector, and private industry. I have successfully supervised and mentored multiple physicians, neurologists, BSc, MSc, and PhD candidates into their successful professional and academic careers.

Organizations

Career arc: 1989 - 2026

Source: PubMed

Sir Charles Gairdner Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 301

Citations

Citations: 13 973 1st author: 21 Last author: 72 Unique author: 5


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The Application of Treatment Guidelines in Multiple Sclerosis Care: A Qualitative Analysis of Barriers and Facilitators.
PMID 42921594 — sclerosis, multiple sclerosis, health services research, therapeutics, neurologists
Int J MS Care20260
Genome-wide association analyses highlight the neuronal contribution to multiple sclerosis susceptibility.
PMID 42706309 — cells, sclerosis, multiple sclerosis, major histocompatibility complex, genome, genetics, medical
Nat Genet20260
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.
PMID 42543909 — sclerosis, multiple sclerosis, neoplasms, drug therapy, diagnosis, therapeutics, chemotherapy
Mult Scler20260
Causal effects of multiple sclerosis therapies in left-truncated registry data.
PMID 42479470 — registries, sclerosis, multiple sclerosis, bias, demyelinating diseases, therapeutics
Mult Scler20260
Meningoencephalitis and tumefactive demyelination are dominant factors for headaches in myelin oligodendrocyte glycoprotein antibody-associated disease.
PMID 42214252 — headache, multiple sclerosis, oligodendroglia, myelin-oligodendrocyte glycoprotein, meningoencephalitis, glycoproteins, risk factors
Mult Scler Relat Disord20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Completed 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 8

LeadR Networks

Main global connection map